full issue - Association of Biotechnology and Pharmacy

More documents

Recommendations

Info

Current Trends in Biotechnology and PharmacyVol. 5 (2) 1110-1122 April 2011. ISSN 0973-8916 (Print), 2230-7303 (Online)11212. Tadros, .T. (1983) In: P.Becher (Ed.),Encyclopedia of emulsion Technology, vol.1Marcel Deckker, New york, , pp. 129-285.3. Carsten, B., Androes, S., Adrian, F., Torsten,W. and Ralph, L. (2007). Novel poloxamer– based nano emulsions to enhance theintestinal absorption of active compounds.Int.J. pharm., 329, 173-181.4. Shah, P., Bhalodia, D. and Shelat, P. (2010).Nano emulsion: A pharmaceutical Review,Sys Rev Pharm. 1.5. Lennart, L., Pia, S., Jan, W. and Ulf, O.(2007). Amorphous Drug Nano Suspension;Particle dissolution and crystal growth,Langmuir, 23, 9866-9874.6. Lukyanenko, V. (2007). Delivery of nanoobjectsto functional sub-domains of healthyand failing cardiac myocytes. Nanomedicine, 2, 831-46.7. Ahmed, A., David, M., Duane, A., Natalie,D. and Michael, J. (2007) PopulationPharmacokinetics of S( – )-Carvedilol inHealthy Volunteers After Administration ofthe Immediate-Release (IR) and the NewControlled-Release (CR) Dosage Forms ofthe Racemate, The AAPS Journal, 9.8. Varsha, P., Abhishek, K., Vinod, V., Sheetal,D. and Leenata, M. (2009). Ternarycomplexation of carvedilol,? - cyclodextrinand citric acid for mouth-dissolving tabletformulation, Acta Pharm. 59, 121–132.9. Vamshi, V., Chandrasekhar, K., Ramesh, G.and Madhusudan Rao, M. (2007).Development of Mucoadhesive Patches forBuccal Administration of Carvedilol, CurrentDrug Delivery, 4, 27-39.10. Enas, A., Ehab, R. and Magdy, I. (2009).Preparation and Evaluation of SelfnanoemulsifyongTablets of Carvedilol,AAPS PharmaciTech, 10.11. Ramesh, G., Vamshi, V., Kishan, V andMadhusudan Rao, Y. (2007). Studies on theinfluence of penetration enhancers on invitro permeation of carvedilol across ratabdominal skin, Current Trends inBiotechnology and Pharmacy, 1 62-69.12. Yuvaraj, S., Chetan Singh, T. and AnshuSharma, C. (2007). Development andevaluation of carvedilol transdermal patches.Acta Pharm, 57, 151–159.13. Akhayachatra, C., Pranee,t O., Tanasait, N.,Natthan, C., Warisadasila, O. and Uracha,R.(2007). Physicochemical properties of lipidemulsions formulated with high-load alltrans-retinoicacid. PDA J. Pharm. Sci.Technol. 61, 461-471.14. Endabetla, V., Kandadi, P. and Veerabrahma,K. (2009). Preparation, characterization andin vivo pharmacodynamic evaluation ofParentral diclofenac submicron lipidemulsions, PDA J. Pharm. Sci. Technol.,63,380-389.15. Meyer, S., Berrut, S., Goodenough, T.,Rajendram, V., Pinfield, V. and Povey, M.(2006). A comparative study of ultra soundand laser light diffraction techniques forparticle size determination in dairybeverages. Meas.Sci.Technolo., 17, 289-297.16. Liberman, H., Rieger, M. and Banker, G.(1988). Pharmaceutical dosageforms:Disperse systems; Marcel Dekker: NewYork, Vol.1.17. Jawahar, N., Nagasamy, D., Sureshkumar,R., Senthil, V., Ganesh, K., Vinoth, P.,Sumeet, S. and Samantha, K. (2009).Development and characterization ofKoteswari Poluri et al
Current Trends in Biotechnology and PharmacyVol. 5 (2) 1110-1122 April 2011. ISSN 0973-8916 (Print), 2230-7303 (Online)1122PLGA-nanoparticles containing carvedilol,J.Pharm. Sci & Res, 3, 123-128.18. Tushar, K., Aliasgar, S. and Mansoor, M.(2008). Improved bioavailability and brainTransport of Saquinqvir upon Administrationin Novel Nanoemulsion Formulations, Int. JPharma. 347, 93-101.19. Sankar, D., Ramakrishna Rao, M.,Sambandam, G. and Pugalendi, K. (2006).Effect of Sesame Oil on Diuretics or ß-blockers in the Modulation of BloodPressure, Anthropometry, Lipid Profile, andRedox status, yale journal of biology andmedicine 79, 19-26.20. Manjunath, K., Reddy, J. andVenkateshwarlu,V. (2005). Solid lipid nanoparticles as drug delivery systems,Experimental clinical pharmacology, 27, 127-144.21. Torrey, D., Michael, K. and Kevin, M.(2006). Optimizing silicone emulsion stabilityusing zeta potential, American LaboratoryNews, June/July.22. Yi Z., Changguang, W., Albert, H., Chow,K., Tao, G., Zhirong, Z. and Ying, Z. (2010).Self nano emulsifying drug delivery system(SNEDDS) for oral delivery of Zedoaryessential oil: Formulation and bioavailabilitystudies, Int J Pharm. 383, 170-177.23. Esposito, Pierandrea, Coceani, Nicoletta,Del Curto, Maria Dorly, Carli and Fabio.(2004). Biphasic multicomponentpharmaceutical dosageforms containingsubstances able to modify the partitioningof drugs, European Patent EP0917457.24. Yun, L., Jingying, J., Gangyi, L., Chuan, L.,Yanmei, L. and Chen, Y. (2009).Pharmacokinetics and Bioequivalenceevaluation of two formulations of 10-mgamlodipine besylate: An open-label, healthyChinese male volunteers, ClinicalTherapeutics, 31, 777-783.25. Tiwari, S. and Amiji, M. (2006). Improvedoral delivery paclitaxel followingadministration in nano emulsionformulations, J nanosci NanoTechnolo, 6,3215-21.26. Hirunpanchi, V., Katagi, J., Sethabouppha,B. and Sato, H. (2005). Demonstration ofdocosahexanoic acid as a bioavailabilityenhancer for CYP3A substrates: In vitroand in vivo evidence using cyclosporine inrats, Drug Metab Disp, 34, 305-310.Regeneration in Parthenium argentatum
Page 3 and 4: ISSN 0973-8916Current Trends inBiot
Page 6 and 7: Current Trends in Biotechnology and
Page 43: Current Trends in Biotechnology and
Page 55: Current Trends in Biotechnology and
Page 94 and 95:
Current Trends in Biotechnology and
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 133:
(December 7-9, 2011)Venue: Karunya
show all

full issue - Association of Biotechnology and Pharmacy

Create successful ePaper yourself

Delete template?

Save as template?